Neither supplement, here utilized as drugs, made a difference in threat for occurrence atrial fibrillation in the 5-year trial. And a secondary level of sensitivity analysis consisted of a cautionary signal. Medscape Medical News
Find Out More
- Wed. Nov 6th, 2024
Latest News